GlassScriptPhysician profile
Shelly Ludwig
NPI 1801860937
$2,299.44
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $421 · 2020: $315 · 2021: $610 · 2022: $851 · 2023: $102.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $102.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $102.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $467.86 | 2019-2023 | |
| Janssen Biotech, INC. | $234.18 | 2019-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $212.09 | 2019-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $180.38 | 2019-2022 | |
| Celgene Corporation | $170.73 | 2021-2023 | Zeposia |
| Nestle Healthcare Nutrition INC. | $129.52 | 2020-2023 | |
| Ethicon US, LLC | $121.84 | 2021 | |
| Janssen Scientific Affairs, LLC | $117.82 | 2022 | |
| Covidien LP | $114.47 | 2019 | |
| Pfizer INC. | $110.22 | 2019-2023 | |
| E.R. Squibb & Sons, L.L.C. | $90.91 | 2022 | |
| Daiichi Sankyo INC. | $78.73 | 2021-2023 | Injectafer |
| Ironwood Pharmaceuticals, INC | $70.94 | 2019-2021 | |
| Alfasigma USA, INC. | $54.10 | 2020-2021 | |
| Allergan, INC. | $27.63 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intercept Pharmaceuticals, INC. | $27.62 | 2020 | |
| Lucid Diagnostics INC. | $17.49 | 2022 | |
| Ferring Pharmaceuticals INC. | $17.32 | 2023 | Rebyota |
| Braintree Laboratories, INC. | $15.07 | 2022 | |
| Merck Sharp & Dohme LLC | $14.62 | 2021 | |
| Evoke Pharma, INC. | $13.08 | 2021 | |
| Genzyme Corporation | $12.82 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shelly Ludwig listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.